# The Role of Oncotype DX® Recurrence Score in Predicting Axillary Response After Neoadjuvant Chemotherapy in Breast Cancer

**Type:** Papers  
**Canonical URL:** https://scholariq.org/papers/the-role-of-oncotype-dx-recurrence-score-in-predicting-axillary-response-after/

## Facts

| Field | Value |
| --- | --- |
| Author Names | Jaime Pardo,Betty Fan,Alessandra Mele,Stephanie K. Serres,Monica G. Valero,Isha Emhoff,Amulya Alapati,Ted A. James |
| Citations | 24 |
| DOI | 10.1245/s10434-020-09382-w |
| Fields | Biochemistry, Genetics and Molecular Biology,Medicine |
| Open Access | false |
| OA Status | closed |
| OpenAlex ID | https://openalex.org/W3119100277 |
| PMID | 33393046 |
| Type | article |
| Year | 2021 |

## Paper authors

- [Amulya Alapati](https://scholariq.org/researchers/amulya-alapati/)

## Paper journal

- [Annals of Surgical Oncology](https://scholariq.org/journals/annals-of-surgical-oncology/)

## Paper primary topic

- [Breast Cancer Treatment Studies](https://scholariq.org/topics/breast-cancer-treatment-studies/)

## Paper topics

- [Breast Cancer Treatment Studies](https://scholariq.org/topics/breast-cancer-treatment-studies/)
- [Breast Lesions and Carcinomas](https://scholariq.org/topics/breast-lesions-and-carcinomas/)
- [Breast Implant and Reconstruction](https://scholariq.org/topics/breast-implant-and-reconstruction/)

---
Source: ScholarIQ — public research metadata, principally OpenAlex. See https://scholariq.org/sources/ for provenance and https://scholariq.org/methodology/ for what these figures mean.